The role of HPV in head and neck cancer and review of the HPV vaccine
Top Cited Papers
- 1 October 2011
- journal article
- review article
- Published by Elsevier in Preventive Medicine
- Vol. 53, S5-S11
- https://doi.org/10.1016/j.ypmed.2011.08.001
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort studyThe Lancet, 2011
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in MalesNew England Journal of Medicine, 2011
- Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancersBritish Journal of Cancer, 2011
- Worsening disparities in HPV vaccine utilization among 19–26 year old womenVaccine, 2010
- Impact of vaccinating boys and men against HPV in the United StatesVaccine, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortiumInternational Journal of Epidemiology, 2009
- Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United StatesBMJ, 2009
- Understanding the Reasons Why Mothers Do or Do Not Have Their Adolescent Daughters Vaccinated Against Human PapillomavirusAnnals of Epidemiology, 2009
- The economic burden of noncervical human papillomavirus disease in the United StatesAmerican Journal of Obstetrics and Gynecology, 2008